Zhang, Mengyi
Wang, Baocheng
Chong, Qing-Yun
Pandey, Vijay
Guo, Zhirong
Chen, Ru-Mei
Wang, Lingzhi
Wang, Yanxin
Ma, Lan
Kumar, Alan P.
Zhu, Tao http://orcid.org/0000-0003-4130-1144
Wu, Zheng-Sheng http://orcid.org/0000-0002-8695-5582
Yin, Zhinan
Basappa,
Goh, Boon-Cher
Lobie, Peter E.
Article History
Received: 24 April 2019
Revised: 7 October 2019
Accepted: 8 October 2019
First Online: 4 November 2019
Conflict of interest
: P.E.L. and T.Z. have consulted for Perseis Therapeutics Ltd. P.E.L. is also named on PCT application numbers WO 2006/69253 and WO 2008/042435 and US provisional application number 61/059558 and derivatives thereof. V.P., B. and P.E.L. are named as inventors on PCT application SG2018/050277 “Compounds, As Inhibitors of TFF3 Dimerization, Methods and Applications Thereof”. M.Z., B.W., Q.Y.C., Z.G., R.M.C., L.W., L.M., A.P.K., Z.S.W., Z.Y. and B.C.G. declare no conflict of interest.